Xcout Intel
EGenesis competitors & alternatives
The 12 closest competitors and alternatives to EGenesis among therapeutics companies — ranked by similarity to what EGenesis actually does, not by market-cap band.
Subscribe to see EGenesis’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About EGenesis
eGenesis, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing advanced genome-editing solutions. The company utilizes its proprietary platform to work on xenotransplantation and address organ shortages for human patients.
EGenesis at a glance
EGenesis is a therapeutics company headquartered in United States. Its most recent funding round, Series D, raised $190M in September 2024. Xcout tracks 15 named people at EGenesis, including Mike Curtis (President and CEO). Xcout recorded 22 job postings from EGenesis in the last 90 days.
EGenesis leadership
- Mike CurtisPresident and CEO
- Mike Curtis, Ph.D.President & Chief Executive Officer
- Glenn VraniakChief Financial Officer
- Jay Barth, M.D.Chief Medical Officer
- Jennifer BergheiserChief Commercial Officer
- Susan Low, Ph.D.SVP, Development
9 more named people on record for EGenesis, with roles, board committees and tenure — see the full roster →
EGenesis funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $190M | 12 named | |
| SEC Form D filing | $25.4M | — | |
| SEC Form D filing | $125M | — | |
| SEC Form D filing | $100M | — | |
| SEC Form D filing | $12.6M | — | |
| SEC Form D filing | $2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at EGenesis
Xcout recorded 22 job postings from EGenesis in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see EGenesis's hiring signals →
Top 12 EGenesis competitors
Ranked by semantic similarity — how close each company is to EGenesis by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Biotechnology
EdiGene is a clinical-stage biotechnology company founded in 2015 that focuses on translating gene-editing technologies into therapeutic products. Headquartered in Beijing, China, the company also operates research and office facilities in locations such as Shanghai, Guangzhou, and the United States.
Biotechnology
KOMO Biosciences is a biotechnology research company headquartered in Cambridge, Massachusetts. The company specializes in next-generation precision genome engineering driven by highly efficient, evolved integrases.
Biotechnology
Colossal Biosciences is a biotechnology and genetic science company headquartered in Dallas, Texas, specializing in de-extinction initiatives and advanced genomics research.
Biotech
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Biotechnology
Carmine Therapeutics, Inc. is an EVX Ventures company headquartered in Cambridge, Massachusetts, focused on developing novel gene therapies.
Biotechnology
Exsilio Therapeutics Inc. is a biotechnology company headquartered in Boston, Massachusetts, founded in 2022 to pioneer genomic medicines and advanced genetic therapies.
Biotech
Endsulin, Inc. is a biotechnology company developing a liver-directed gene therapy for Type 1 Diabetes. Its proprietary technology aims to re-engineer liver cells to restore the body's natural ability to produce and regulate insulin, eliminating the need for artificial insulin delivery methods.
Biotech
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Biotechnology
Base Therapeutics is a biotechnology company that develops next-generation gene editing technologies, including its proprietary AccuBase base editing system and enhanced prime editing technology. The company focuses on creating therapeutic solutions for cancer and genetic diseases, alongside engineered immune cell therapies such as BASE-NK and CAR-T products. It serves patients and partners with pharmaceutical and agricultural enterprises by licensing its precision gene editing tools.
Biotechnology
Epicrispr Biotechnologies is a pioneering therapeutics company dedicated to developing advanced genetic medicines. The organization focuses on scientific research, platforms, and clinical pipelines to treat serious diseases.
Biotechnology
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of EGenesis and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for EGenesisand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →